Takeda America takes over URL Pharma
Takeda will begin the integration of URL Pharma and will right away assume responsibility for the marketing and promotion of URL’s Colcrys (colchicine) for the treatment and prevention
The US Food and Drug Administration (FDA) has issued traditional approval to Novartis for Fabhalta (iptacopan), to slow the decline of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.
The manufacturing plant produces D-Ribose, through quality fermentation and applied extraction and refinement techniques, the company said. Bioenergy Life Science president Tom VonderBrink said that the BRC accreditation